Physician profile
Barry Robert Sanchez
NPI 1609934652
$581,572.27
in general payments reported to CMS, 2019-2025
7 companies · $60K in 2025
The $60K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,071 · 2020: $1,813 · 2021: $25K · 2022: $117K · 2023: $194K · 2024: $178K · 2025: $60K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $339K · Travel and Lodging: $56K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21K · Food and Beverage: $15K · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $339,139.13 |
| Travel and Lodging | $55,606.24 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21,000.00 |
| Food and Beverage | $15,182.11 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $578,500.91 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Covidien LP | $1,919.94 | 2019-2020 | |
| Medtronic, INC. | $814.69 | 2021-2023 | Signia |
| Davol INC. | $114.33 | 2019 | |
| Innovation Technologies INC | $112.90 | 2024 | Irrisept |
| Novo Nordisk INC | $69.50 | 2022-2025 | Wegovy |
| Medline Industries LP | $40.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.